This site is intended for health professionals only
Hospital Healthcare Europe
Register
Login
Linkedin
Facebook
Select Language
English
French
German
Italian
Spanish
News
In depth
Views
Conference reports
Reviews & Research
Practice
Health technology
Sustainability
Clinical
Cardiovascular
Dermatology
Emergency and critical care
Gastroenterology
Haematology
Immunology
Medicines safety
Mental health
Neurology
Oncology
Paediatrics
Respiratory
Rheumatology
Events
Upcoming events
On-demand learning
Clinical Excellence Catch-up
Partners
Register
Login
News
In depth
Views
Conference reports
Reviews & Research
Practice
Health technology
Sustainability
Clinical
Cardiovascular
Dermatology
Emergency and critical care
Gastroenterology
Haematology
Immunology
Medicines safety
Mental health
Neurology
Oncology
Paediatrics
Respiratory
Rheumatology
Events
Upcoming events
On-demand learning
Clinical Excellence Catch-up
Partners
Register
Login
Home
>
Opinion/comment
Opinion/comment
Ozurdex receives positive opinion from CHMP for treatment of macular oedema
Boosting healthcare delivery via clinician-pharmacy interoperability
Unit dose dispensing in the UK: time for a re-think?
Britain a nation of ‘pill poppers’
Science group backs treatments
The power of partnerships highlighted by Office for Life Sciences Report
International politics and drugs
A primary need to ensure optimal clinical pharmacy services for our old CHUMS
Minister rejects supermarket threat
European Symposium on Clinical Pharmacy: recognising Clinical Pharmacy: recognising achievements and challenges
The competition gets dirty
Injecting clarity
« Previous
1
2
3
4
5
…
8
Next »
Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe
x
Search for: